4McDermott. D. High-Dose IL-2 Is Standard in Advanced Renal Cell Cancer[N]. Oncology News International. 2001, 10, 2- 3.
5DiMeco F, Rhines LD, Hanes J, et al. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats[J]. J Neurosurg,2000, 92(3) : 419- 427.
6Kikuchi T, Joki T, Abe T, et al. Antitumor activity of killer cells stimulated with both inter leukin-2 and interleukin-12 on mouse glioma cell[J]. J Immunother, 1999, 22(3) : 245 - 250.
7Fathallah-Shaykh HM, Gao W, Cho M, et al. Priming in the brain, and immunologically privileged organ, elicits anti-tumor immunity[J]. Int J Cancer, 1998, 75(2) : 266- 267.
8Knupfer MM, Knupfer H, Van Cool S, et al. Interferon gamma inhibits proliferation and hyaluronic acid adhesion of human malignant glioma cells in vitro [J]. Cytokine , 2000 , 12(4) :409 - 412.
9Suzuki Y, Fujimiya Y, Ohno T, et al. Enhancing effect of tumor necrosis factor(TNF)-alpha, but not IFN-gamma, on the tumor-specific cytotoxicity of gammadelta T cells from gliolbastoma patients[J]. Cancer Lett, 1999, 140.
10Yamamoto M, Fukushima T, Hayashi S, et al. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type1(TNFR-1)and c-Myc with the linical course in the treatment of malighnant astrocytomas with recombinant mutant human tumor necrosis factor-alpha(TNF--SAM2) [J]. Anticancer Res,2000, 20(IC): 611 - 618.
